These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33243603)

  • 1. A novel target anti-interleukin-13 receptor subunit alpha-2 monoclonal antibody inhibits tumor growth and metastasis in lung cancer.
    Raza G; Yunus FU; Mangukiya HB; Merugu SB; Mashausi DS; Zeling W; Negi H; Zhou B; Roy D; Wu Z; Li D
    Int Immunopharmacol; 2021 Jan; 90():107155. PubMed ID: 33243603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer.
    Bartolomé RA; Jaén M; Casal JI
    Br J Cancer; 2018 Oct; 119(8):940-949. PubMed ID: 30318506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice.
    Xie M; Wu XJ; Zhang JJ; He CS
    Oncotarget; 2015 Oct; 6(32):32902-13. PubMed ID: 26418721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and immunotherapeutic implications for a novel antibody targeting interleukin (IL)-13 receptor α2.
    Balyasnikova IV; Wainwright DA; Solomaha E; Lee G; Han Y; Thaci B; Lesniak MS
    J Biol Chem; 2012 Aug; 287(36):30215-27. PubMed ID: 22778273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors.
    Kim JW; Young JS; Solomaha E; Kanojia D; Lesniak MS; Balyasnikova IV
    Sci Rep; 2015 Dec; 5():18133. PubMed ID: 26656559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants.
    Krenciute G; Prinzing BL; Yi Z; Wu MF; Liu H; Dotti G; Balyasnikova IV; Gottschalk S
    Cancer Immunol Res; 2017 Jul; 5(7):571-581. PubMed ID: 28550091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.
    He H; Xu J; Nelson PS; Marshall FF; Chung LW; Zhau HE; He D; Wang R
    Prostate; 2010 Jun; 70(9):993-1001. PubMed ID: 20166133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.
    Nguyen V; Conyers JM; Zhu D; Gibo DM; Hantgan RR; Larson SM; Debinski W; Mintz A
    Neuro Oncol; 2012 Oct; 14(10):1239-53. PubMed ID: 22952195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting and pharmacology of an anti-IL13Rα2 antibody and antibody-drug conjugate in a melanoma xenograft model.
    Gupta P; Jiang ZK; Yang B; Manzuk L; Rosfjord E; Yao J; Lemon L; Noorbehesht K; David J; Puthenveetil S; Casavant JM; Muszynska E; Li F; Leal M; Sapra P; Giddabasappa A
    MAbs; 2021; 13(1):1958662. PubMed ID: 34347577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
    Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
    Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma.
    Jain M; Zhang L; He M; Patterson EE; Nilubol N; Fojo AT; Joshi B; Puri R; Kebebew E
    Cancer; 2012 Nov; 118(22):5698-708. PubMed ID: 22570059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Recombinant Modified Vaccinia Ankara Virus expressing Interleukin-13 Receptor α2 Antigen for Potential Cancer Immunotherapy.
    Sato Y; Vatsan R; Joshi BH; Husain SR; Puri RK
    Curr Mol Med; 2024; 24(6):758-770. PubMed ID: 36999709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine induction of VCAM-1 but not IL13Rα2 on glioma cells: a tale of two antibodies.
    Mahadev V; Starr R; Wright SL; Martinez C; Jensen MC; Barish ME; Forman SJ; Brown CE
    PLoS One; 2014; 9(5):e95123. PubMed ID: 24787244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma.
    Krenciute G; Krebs S; Torres D; Wu MF; Liu H; Dotti G; Li XN; Lesniak MS; Balyasnikova IV; Gottschalk S
    Mol Ther; 2016 Feb; 24(2):354-363. PubMed ID: 26514825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells redirected to interleukin-13Rα2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1.
    Krebs S; Chow KK; Yi Z; Rodriguez-Cruz T; Hegde M; Gerken C; Ahmed N; Gottschalk S
    Cytotherapy; 2014 Aug; 16(8):1121-31. PubMed ID: 24841514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.
    Kim KY; Yoon M; Cho Y; Lee KH; Park S; Lee SR; Choi SY; Lee D; Yang C; Cho EH; Jeon SD; Kim SH; Kim C; Kim MG
    J Exp Clin Cancer Res; 2019 Aug; 38(1):363. PubMed ID: 31426843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.
    Pituch KC; Miska J; Krenciute G; Panek WK; Li G; Rodriguez-Cruz T; Wu M; Han Y; Lesniak MS; Gottschalk S; Balyasnikova IV
    Mol Ther; 2018 Apr; 26(4):986-995. PubMed ID: 29503195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy.
    Gu A; Bai Y; Zhang C; Xu C; An Z; Zhang Y; Zhong SH; Hu Y; Zhong X
    Cancer Immunol Immunother; 2023 Jul; 72(7):2393-2403. PubMed ID: 36991262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells.
    Brown CE; Starr R; Aguilar B; Shami AF; Martinez C; D'Apuzzo M; Barish ME; Forman SJ; Jensen MC
    Clin Cancer Res; 2012 Apr; 18(8):2199-209. PubMed ID: 22407828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma.
    Okamoto H; Yoshimatsu Y; Tomizawa T; Kunita A; Takayama R; Morikawa T; Komura D; Takahashi K; Oshima T; Sato M; Komai M; Podyma-Inoue KA; Uchida H; Hamada H; Fujiu K; Ishikawa S; Fukayama M; Fukuhara T; Watabe T
    Sci Rep; 2019 Feb; 9(1):1281. PubMed ID: 30718742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.